Continuous infusion versus intermittent bolus of ceftazidime for the treatment of nosocomial pneumonia

被引:0
|
作者
L Lorente
C García
MM Martín
R Galvan
J Villegas
ML Mora
机构
[1] Hospital Universitario de Canarias,Department of Intensive Care
来源
Critical Care | / 7卷 / Suppl 2期
关键词
Minimum Inhibitory Concentration; Clinical Efficacy; Continuous Infusion; Aminoglycoside; Quinolone;
D O I
10.1186/cc2017
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Pharmacodynamic interest of ceftazidime continuous infusion versus intermittent bolus administration in patients with severe nosocomial pneumonia
    Cousson, Y
    Hoizey, G
    Floch, T
    Raclot, P
    Petit, JS
    Vernet-Garnier, V
    Lamiable, D
    Leon, A
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S111 - S111
  • [2] Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia
    McNabb, JCJ
    Nightingale, CH
    Quintiliani, R
    Nicolau, DP
    PHARMACOTHERAPY, 2001, 21 (05): : 549 - 555
  • [3] Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia
    Cousson, J
    Floch, T
    Vernet-Garnier, V
    Appriou, M
    Petit, JS
    Jovenin, N
    Lamiable, D
    Hoizey, G
    PATHOLOGIE BIOLOGIE, 2005, 53 (8-9): : 546 - 550
  • [4] Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
    L Lorente
    S Huidobro
    M Martín
    M Mora
    Critical Care, 9 (Suppl 1):
  • [5] Continuous infusion versus intermittent infusion of ceftazidime for the treatment of pneumonia caused by Pseudomonas aeruginosa
    L Lorente
    C García
    M Martín
    M Mora
    Critical Care, 9 (Suppl 1):
  • [6] Pharmacokinetics and Pharmacodynamics of Continuous and Intermittent Ceftazidime during the Treatment of Nosocomial Pneumonia
    David P. Nicolau
    JoCarol McNabb
    Melinda K. Lacy
    Jing Li
    Richard Quintiliani
    Charles H. Nightingale
    Clinical Drug Investigation, 1999, 18 : 133 - 139
  • [7] Pharmacokinetics and pharmacodynamics of continuous and intermittent ceftazidime during the treatment of nosocomial pneumonia
    Nicolau, DP
    McNabb, JC
    Lacy, MK
    Li, J
    Quintiliani, R
    Nightingale, CH
    CLINICAL DRUG INVESTIGATION, 1999, 18 (02) : 133 - 139
  • [8] Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia
    Nicolau, DP
    McNabb, J
    Lacy, MK
    Quintiliani, R
    Nightingale, CH
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (06) : 497 - 504
  • [9] Piperacillin/tazobactam administered by continuous or intermittent infusion for the treatment of nosocomial pneumonia
    L Lorente
    S Palmero
    J Jiménez
    J Iribarren
    R Galván
    J Martínez
    C García
    J Castedo
    M Brouard
    M Martín
    M Mora
    Critical Care, 13 (Suppl 1):